Literature DB >> 22081615

Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease.

Melania Manco1.   

Abstract

Compelling evidence supports the concept that nonalcoholic fatty liver disease (NAFLD) represents the hepatic component of metabolic syndrome (MetS). Intrahepatic fat seems to predict more strongly than does visceral adiposity an individual's cardiovascular risk and the likelihood that metabolic abnormalities are present in youth. Young individuals with fatty liver are more insulin resistant and present with a higher prevalence of metabolic abnormalities than do individuals without intrahepatic fat accumulation. They also present with a certain endothelial dysfunction and greater carotid intima-media thickness. Conversely, youth with MetS seem to have an increased risk of developing liver inflammation, a condition termed nonalcoholic steatohepatitis (NASH), and fibrosis. In the context of MetS, the liver is central in that it can drive both hepatic and systemic insulin resistance, trigger low-grade inflammation, and promote atherogenic processes. In the context of MetS, NAFLD and altered carbohydrate metabolism track from childhood to adulthood. Thus, prevention, recognition, and effective treatment of these two abnormalities may limit the burden of morbidity and mortality associated with obesity and may delay onset of cardiovascular disease in early adulthood. The present review aims at systematically presenting evidence of the critical interplay of fatty liver and altered glucose metabolism in youth. It attempts to provide pathogenetic explanations for such an association and the rationale for its treatment, with particular regard to nutritional interventions. Key teaching points: Overweight and obese youth should be screened for fatty liver disease once after puberty by liver function tests and ultrasonography. Screening for fatty liver should be accurately performed in young patients with features of metabolic syndrome. Obese patients with fatty liver are at increased risk for altered glucose metabolism, thus they should undergo an oral glucose tolerance test. A nutritional and behavioral intervention aimed at achieving a permanent change of the lifestyle in patients and their parents is recommended.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081615     DOI: 10.1080/07315724.2011.10719972

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  12 in total

Review 1.  Chromatin Modifications Associated With Diabetes and Obesity.

Authors:  Dustin E Schones; Amy Leung; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

2.  Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study.

Authors:  Federica Del Chierico; Melania Manco; Simone Gardini; Valerio Guarrasi; Alessandra Russo; Marzia Bianchi; Valentina Tortosa; Andrea Quagliariello; Blegina Shashaj; Danilo Fintini; Lorenza Putignani
Journal:  Acta Diabetol       Date:  2021-03-22       Impact factor: 4.280

3.  Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Patricia G Yancey; Brian J Van Lenten; Justin R Savage; Sergio Fazio; MacRae F Linton; Sean S Davies
Journal:  Antioxid Redox Signal       Date:  2015-03-18       Impact factor: 8.401

4.  Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice.

Authors:  Hao Chiang; Jinq-Chyi Lee; Hsiu-Chen Huang; Hsing Huang; Hui-Kang Liu; Cheng Huang
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

5.  Bone marrow adipose tissue content in Latino adolescents with prediabetes and obesity.

Authors:  Kiley B Vander Wyst; Houchun H Hu; Armando Peña; Micah L Olson; Smita S Bailey; Gabriel Q Shaibi
Journal:  Obesity (Silver Spring)       Date:  2021-09-28       Impact factor: 5.002

6.  Back to past leeches: repeated phlebotomies and cardiovascular risk.

Authors:  Melania Manco; Josè Manuel Fernandez-Real
Journal:  BMC Med       Date:  2012-05-30       Impact factor: 8.775

Review 7.  Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics.

Authors:  Melania Manco
Journal:  Children (Basel)       Date:  2017-08-14

8.  Insulin sensitivity from preschool to school age in patients with severe obesity.

Authors:  Melania Manco; Maria Rita Spreghini; Rosa Luciano; Cecilia Pensini; Rita Wietrzycowska Sforza; Carmela Rustico; Marco Cappa; Giuseppe Stefano Morino
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

9.  Liver enzymes and metabolic syndrome: a large-scale case-control study.

Authors:  Lu Zhang; Xiangyu Ma; Zhi Jiang; Kejun Zhang; Mengxuan Zhang; Yafei Li; Xiaolan Zhao; Hongyan Xiong
Journal:  Oncotarget       Date:  2015-09-29

10.  Predictive Value of Serum Gamma-glutamyltranspeptidase for Future Cardiometabolic Dysregulation in Adolescents- a 10-year longitudinal study.

Authors:  Chien-Ming Lin; Chang-Hsun Hsieh; Chien-Hsing Lee; Dee Pei; Jiunn-Diann Lin; Chung-Ze Wu; Yao-Jen Liang; Yi-Jen Hung; Yen-Lin Chen
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.